WO2018080118A3 - 건선 관련 질환 진단용 조성물 - Google Patents

건선 관련 질환 진단용 조성물 Download PDF

Info

Publication number
WO2018080118A3
WO2018080118A3 PCT/KR2017/011712 KR2017011712W WO2018080118A3 WO 2018080118 A3 WO2018080118 A3 WO 2018080118A3 KR 2017011712 W KR2017011712 W KR 2017011712W WO 2018080118 A3 WO2018080118 A3 WO 2018080118A3
Authority
WO
WIPO (PCT)
Prior art keywords
psoriasis
related diseases
diagnosis
composition
present specification
Prior art date
Application number
PCT/KR2017/011712
Other languages
English (en)
French (fr)
Other versions
WO2018080118A2 (ko
Inventor
빈범호
서주연
조은경
이태룡
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Publication of WO2018080118A2 publication Critical patent/WO2018080118A2/ko
Publication of WO2018080118A3 publication Critical patent/WO2018080118A3/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/205—Scaling palpular diseases, e.g. psoriasis, pytiriasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

본 명세서는 건선 관련 질환을 진단하기 위한 마커 발굴, 이를 이용한 건선 관련 질환 진단 및 관련 물질 스크리닝 방법에 관한 것으로서, 본 명세서의 일 측면을 이용하여 건선 관련 질환을 보다 효과적으로 관리할 수 있을 것이므로, 본 명세서는 일 관점에서 관련 산업 발전에 큰 기여를 할 것이다.
PCT/KR2017/011712 2016-10-24 2017-10-23 건선 관련 질환 진단용 조성물 WO2018080118A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2016-0138330 2016-10-24
KR1020160138330A KR20180044603A (ko) 2016-10-24 2016-10-24 건선 관련 질환 진단용 조성물

Publications (2)

Publication Number Publication Date
WO2018080118A2 WO2018080118A2 (ko) 2018-05-03
WO2018080118A3 true WO2018080118A3 (ko) 2018-08-09

Family

ID=62023768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/011712 WO2018080118A2 (ko) 2016-10-24 2017-10-23 건선 관련 질환 진단용 조성물

Country Status (2)

Country Link
KR (1) KR20180044603A (ko)
WO (1) WO2018080118A2 (ko)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101490585B1 (ko) * 2013-04-15 2015-02-11 가톨릭대학교 산학협력단 건선 진단용 유전자 마커 및 이를 이용한 건선 진단 방법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101490585B1 (ko) * 2013-04-15 2015-02-11 가톨릭대학교 산학협력단 건선 진단용 유전자 마커 및 이를 이용한 건선 진단 방법

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIN, B.-H. ET AL.: "An Acrodermatitis Enteropathica-associated Zn Transporter, ZIP4, Regulates Human Epidermal Homeostasis", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 137, 24 February 2017 (2017-02-24), pages 874 - 883, XP055534484 *
INOUE, Y. ET AL.: "Z1P2 Protein, a Zinc Transporter, Is Associated with Keratinocyte Differentiation", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 289, no. 31, 1 August 2014 (2014-08-01), pages 21451 - 21462, XP055534479 *
JIANG, S. ET AL.: "Biomarkers of an Autoimmune Skin Disease-psoriasis", GENOMICS . PROTEOMICS BIOINFORMATICS, vol. 13, 8 September 2015 (2015-09-08), pages 224 - 233, XP055534473 *
KAMBE, T. ET AL.: "Novel Proteolytic Processing of the Ectodomain of the Zinc Transporter ZlP4 (SLC39A4) during Zinc Deficiency Is Inhibited by Acrodermatitis Enteropathica Mutations", MOLECULAR AND CELLULAR BIOLOGY, vol. 29, no. 1, January 2009 (2009-01-01), pages 129 - 139, XP055534460 *
SCHWARTZ, J. R. ET AL.: "Zinc and Skin Health: Overview of Physiology and Pharmacology", DERMATOLOGIC SURGERY, vol. 31, 2005, pages 837 - 847, XP055534467 *

Also Published As

Publication number Publication date
KR20180044603A (ko) 2018-05-03
WO2018080118A2 (ko) 2018-05-03

Similar Documents

Publication Publication Date Title
AR120262A2 (es) Anticuerpos madurados por afinidad y humanizados para fcrh5 y métodos para su uso
CY1122653T1 (el) Αντισωματα αντι-τιgιτ, αντισωματα αντι-ρvrig και συνδυασμοι εξ αυτων
EP3861437A4 (en) PERFORMING TESTS ON SOFTWARE
BR112017008666A2 (pt) anticorpos anti-fgfr2/3 e métodos de uso dos mesmos
EP4219559A3 (en) Antibodies for lilrb2
BR112019012342A2 (pt) anticorpos il-11
BR112018001955A2 (pt) anticorpos monoclonais contra bcma
WO2018109170A3 (en) Il-11ra antibodies
EP4218810A3 (en) Multivalent meditopes, meditope-binding antibodies and uses thereof
WO2014160441A8 (en) Neuroactive steroids, compositions, and uses thereof
BR112015032718A2 (pt) composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos
CL2016002667A1 (es) Anticuerpos anti-rnf43 novedosos y métodos para su uso
JP2016515397A5 (ko)
BR112016014731A2 (pt) Anticorpos anti-baff
CO2017002472A2 (es) Formulación de acetato de abiraterona
WO2016154623A3 (en) Anti-cd133 monoclonal antibodies and related compositions and methods
EP3791271A4 (en) SET OF SOFTWARE DEVELOPMENT UTILITIES
MX2023012628A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
EP3101475A4 (en) Infrared-sensitive color developing composition, lithographic printing original plate, plate making method for lithographic printing plate, and infrared-sensitive color developer
EP3759469A4 (en) CHAIN TEST DEVELOPMENT DIAGNOSIS ANALYSIS
EP3409709A4 (en) PHOTO-PROCESSING, COMPOUND AND COMPOSITION USED THEREOF
CL2019003557A1 (es) Anticuerpos anti-trkb.
AU2018279738A1 (en) Methods of enhancing development of renal organoids and methods of using the same
EP3654956A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES ASSOCIATED WITH AN IMPRINTING DEFECTIVE
EP4220178A3 (en) Quantitation of tamoxifen and metabolites thereof by mass spectrometry

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17865305

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17865305

Country of ref document: EP

Kind code of ref document: A2